ABSTRACT
Air--conduction (AC) and bone-conduction (BC) thresholds were measured to evaluate standard reference thresholds and recommend revisions to audiometer standards. AC and BC thresholds were measured from listeners with normal hearing (NH) and sensorineural hearing loss (SNHL) at three sites. NH participants (n = 53) were selected based on age (18 – 25 years), normal AC thresholds, tympanometry, otoscopy, and absence of otologic disease. SNHL participants (n = 49) were selected based on AC thresholds, tympanometry, otoscopy, and absence of otologic disease. AC thresholds obtained from NH listeners averaged 3.7 dB HL. Air bone gaps (ABGs) occurred in NH and SNHL listeners above 2000 Hz and SNHL listeners at 250 Hz. Corrections to standard RETSPLs are recommended. ABGs in listeners without conductive pathology result from incorrect reference threshold levels for frequencies above 2000 Hz. False air-bone gaps increase with hearing-loss magnitude, probably due to effects of ambient and internal noise for low-level bone-conduction stimuli. False ABGs place patients at risk for unnecessary medical and surgical intervention. Reference threshold levels should achieve two objectives: 1) AC thresholds from young NH listeners should average 0 dB HL; 2) ABGs from listeners with normal middle-ear function should average 0 dB.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional review board approval was obtained at each site: Arizona State University (ASU; IRB approval STUDY00014515), Cincinnati Children's Hospital Medical Center (CCHMC; IRB approval 2009-0855), and University of South Florida (USF; IRB approval STUDY000265).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Revisions were made to improve clarity.
Data Availability
All data produced in the present work are contained in the manuscript
The Individual threshold data from this study and further methodological details are available at medRxiv (Margolis et al., 2024, DOI 10.1101/2024.08.01.24311230).
